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 Cofactor Genomics is based in St. Louis, MO and provides sequencing and 
analysis services to academic and industry clients.  We are a small company 
committed to changing the service sequencing paradigm by offering our 
customers front-to-back solutions; experimental design, next-generation 
sequencing, and advanced analytics for their work.  Cofactor Genomics was 
founded by individuals with one-of-a-kind experience in Next-Generation 
sequencing technology development. The Cofactor Genomics executive team 
spent a collective 35 years working in the Technology Development Group at 
The Genome Center at Washington University in St. Louis, Missouri. From early 
2004 to late 2008, their primary responsibilities within the group were to 
investigate, evaluate and develop both wet-lab and computational applications 
for emerging Next-Generation sequencing technology platforms. Their 
experience began with beta testing the 454 Life Sciences (now Roche) GS 20, 
continued with beta testing the first serial numbered instrument from Solexa (now 
Illumina), and culminated with beta testing the Applied Biosystems (now Life 
Technologies) SOLiD instrument. Our individual experiences were unique within 
the realm of next-generation sequencing technology, thus extremely 
complimentary for a consolidation and commercialization of skill sets; Matt 
Hickenbotham became a renowned expert in library construction and Next-Gen 
instrumentation, Jon Armstrong emerged as an expert in targeted and reduced 
representation genomic sequencing, and Ryan Richt and Dr. Jarret Glasscock 
were two of the first individuals in the world to characterize the data generated by 
these instruments. It is this early-access wet-lab and computational experience 
with these disruptive sequencing technologies that provided the foundation for 
operations at Cofactor Genomics. 
 Cofactor Genomics has been in operation for 2 years and has already 
established a proven track record of capability, versatility, remarkably consistent 
high quality data generation, and delivering custom data analysis solutions. We 
constructed 268 different sequencing libraries in our first year spanning nearly 
every sequencing application and multiple Next-Gen instrument platforms. This 
feat would be impossible for any firm other than Cofactor to complete in such a 
short time frame, much to the credit of our highly skilled and talented team. We 
pooled our talents to form a company offering customers end-to-end sequencing 
solutions that ultimately allow them to concentrate on what they do best, 
breakthrough research. 
